Clinical Application of Guideline-Directed Medical Therapy in TAVR Patients With Heart Failure and Reduced Ejection Fraction

Heart Failure

Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection Fraction

J Am Coll Cardiol

Min KH, Go AS, Lee K, Parikh RV, Horiuchi KM, Ambrosy AP, Tan TC, Srikanth K, Hamilton SA, Svetlichnaya J, Solomon SD, Inciardi RM, Vardeny O, Vasti E, Sandhu AT, Ku IA, Adatya S, Bhatt AS

doi: 10.1016/j.jacc.2025.05.040

Heart Failure

Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF

Eur J Heart Fail

Malgie J, Wilde MI, Koudstaal S, Denham R, da Fonseca CA, Swart HP, van Ofwegen CEE, Yilmaz A, Pisters R, Linssen GCM, Faber N, van Heerebeek L, van de Swaluw JEC, de Boer RA, Brunner-La Rocca HP, Brugts JJ

doi: 10.1002/ejhf.70006

Heart Failure

Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure and Improved Ejection Fraction

Circulation

Basile C, Lindberg F, Benson L, Guidetti F, Dahlström U, Piepoli MF, Mol P, Scorza R, Maggioni AP, Lund LH, Savarese G

doi: 10.1161/CIRCULATIONAHA.124.072855

Heart Failure

Impact of contemporary guideline-directed medical therapy on secondary mitral and tricuspid regurgitation in heart failure with reduced ejection fraction

Eur J Heart Fail

Naser JA, Rahme SJ, Castrichini M, Ibrahim H, Scott CG, Kennedy AM, Eleid MF, Nkomo VT, Foley DA, McKie PM, Borlaug BA, Pislaru SV, Lin G

doi: 10.1093/ejhf/xuag047

Heart Failure

One-Year Outcomes in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction Prescribed Quadruple Medical Therapy at Discharge

JAMA Cardiol

Greene SJ, Xu H, Chiswell K, Felker GM, Lewsey SC, Divanji PH, Goertz HP, Heitner SB, Shreay S, Pandey A, Yancy CW, Butler J, Fonarow GC

doi: 10.1001/jamacardio.2025.5339

Heart Failure

Survival benefit of guideline-directed medical therapy in older patients with heart failure: a systematic review and meta-analysis

Heart

Tan E, Meei-Wah C, Teo YH, Tan LF, Ho VWT, Lin W, Yeo TC, Wong RCC, Chai P, Kong W, Sia CH

doi: 10.1136/heartjnl-2025-326305

Heart Failure

Cardiac resynchronization therapy for enabling guideline-directed medical therapy optimization in heart failure

Eur J Heart Fail

Tomasoni D, Benson L, Gatti P, Villaschi A, Ljungman C, Metra M, Scorza R, Braunschweig F, Melin M, Rosano G, Böhm M, Butler J, Abraham WT, Mullens W, Gadler F, Linde C, Lund LH, Savarese G

doi: 10.1002/ejhf.3719

Heart Failure

Tachycardia-induced cardiomyopathy in de novo heart failure: prevalence, short-term outcomes, and the role of guideline-directed therapy in ejection fraction improvement

Clin Res Cardiol

Esteban-Fernández A, Gómez-Otero I, López-Fernández S, López-Vilella R, Pastor-Pérez F, Otero-García Ó, Rodríguez-Santamarta M, García-Vega D, Fluvià P, Donoso-Trenado V, Sánchez-Corral E, García-Pinilla JM, Bonilla-Palomas JL, López López A, González-Juanatey JR, Bonet LA

doi: 10.1007/s00392-025-02663-y

Heart Failure

Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical Trial

JAMA Cardiol

Desai AS, Jhund PS, Vaduganathan M, Claggett BL, Cunningham JW, Pabon MA, Lam CSP, Senni M, Shah S, Voors AA, Zannad F, Pitt B, Amarante F, Lay-Flurrie J, Scheerer MF, Lage A, McMurray JJV, Solomon SD

doi: 10.1001/jamacardio.2025.0860

Related content

Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection Fraction

Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF

Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure and Improved Ejection Fraction

Impact of contemporary guideline-directed medical therapy on secondary mitral and tricuspid regurgitation in heart failure with reduced ejection fraction

One-Year Outcomes in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction Prescribed Quadruple Medical Therapy at Discharge

Survival benefit of guideline-directed medical therapy in older patients with heart failure: a systematic review and meta-analysis

Cardiac resynchronization therapy for enabling guideline-directed medical therapy optimization in heart failure

Tachycardia-induced cardiomyopathy in de novo heart failure: prevalence, short-term outcomes, and the role of guideline-directed therapy in ejection fraction improvement

Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical Trial